China Shows Support For Waiving Intellectual Property Rights For Covid Vaccines At United Nations
China has supported the waiver of intellectual property rights for Covid-19 vaccines at the UN, urging all member states and other parties concerned to expand vaccine production and upgrade developing country production capabilities through export, donation, joint research and development, as well as franchised production.
A Chinese envoy said that Beijing, as well as a group of like-minded countries, support the waiver of intellectual property rights for Covid-19 vaccines and urge competent nations to participate actively in international collaboration in this issue.
Earlier this year, Gao Feng, a spokesman for China's Commerce Ministry, said that Beijing supports the World Trade Organization's proposal to enter the consultation stage on an intellectual property protection waiver for Covid-19 vaccines.
Now, Chen Xu, who is the head of the Chinese Mission to the United Nations Office in Geneva, spoke on behalf of a group of countries at the UN Human Rights Council's forty-eighth session, urging all member states and other parties concerned to expand vaccine production and upgrade developing country production capabilities through export, donation, joint research and development, as well as franchised production.
He said: "The Covid-19 pandemic and the emergence of different variants have inflicted severe negative impacts on economic and social development in all countries, especially in developing countries and threatened the health of the people, particularly those in more vulnerable situations."
Chen said that vaccination is a powerful instrument for combating the pandemic, but inequitable distribution, as well as unbalanced vaccination, remain major difficulties, and the immunisation gap must be addressed immediately.
He noted: "We support the call of the United Nations for fair and equitable distribution of and access to COVID-19 vaccines globally and urge all countries to put the rights to life and health first instead of other considerations such as economic, political or other interests."
Waiving Vaccine Intellectual Property Rights
As reported, officials from the United Kingdom and the European Union had expressed scepticism earlier about the utility of a United States proposal to remove patent rights for Covid-19 vaccinations but stated that they were willing to discuss it. At that time, some drug makers and some other nations expressed their disagreement with the plan, claiming that it would not address worldwide immunisation shortages.
Gao said in May this year that "China supports the WTO's proposal on IP exemptions for anti-epidemic materials such as the COVID vaccine to enter the text consultation stage. China will work with all parties to actively participate in consultations and jointly promote a balanced and effective solution.”
However, in June, during a virtual conference among the world leaders, Prime Minister Narendra Modi called for a "one earth, one health" strategy to successfully deal with the worldwide coronavirus pandemic and asked backing from the G7 group to lift patent protections for Covid-19 vaccines. As reported, at that time, his call for adopting this approach received support from the outgoing German Chancellor Angela Merkel.
According to the latest reports, Australia’s Trade Minister Dan Tehan also said that as skyrocketing infection rates throughout the globe prolong the pandemic and create fertile circumstances for new variants, the Oceania country will also support an international push to waive intellectual property rights for Covid-19 vaccines.
Even in New York, Prince Harry and his wife Meghan Markle spoke as part of Global Citizen Live, a 24-hour event calling on world leaders to implement a vaccine equity policy. During the event, Harry said that many countries are ready to manufacture vaccines at their own facilities, but they are unable to do so because “ultra-wealthy pharmaceutical companies” refuse to share the formula.
“These countries have the means, the ability and the workers to start manufacturing. All they are waiting for is the vaccine intellectual property to be waived and the vaccine technology to be transferred,” he added.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.